Metraipolis › archive › dc_f3bf58e2478b
Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system… — Europe PMC PMID:40934012
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40934012
- DOI
- 10.3389/fcimb.2025.1635180
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T08:46:13.885Z
- SHA-256 of the archived text
4dc76aabf9552ea83bf7de5536ea343d4735ed3076e07999c16e98291a594945- Stable URL of this page
https://metraipolis.com/documento/dc_f3bf58e2478b
How to cite
Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system… — Europe PMC PMID:40934012 — Europe PMC (en), https://europepmc.org/article/MED/40934012 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3bf58e2478b (Metraipolis archive dc_f3bf58e2478b, sha256 4dc76aabf9552ea83bf7de5536ea343d4735ed3076e07999c16e98291a594945)
BibTeX
@misc{dcf3bf58e2478b,
title = {Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system… — Europe PMC PMID:40934012},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40934012},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3bf58e2478b; sha256 4dc76aabf9552ea83bf7de5536ea343d4735ed3076e07999c16e98291a594945},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40934012. Agents can read the archived copy with the MCP tool read_document.